440 related articles for article (PubMed ID: 17174973)
21. In vitro proliferation and differentiation of erythroid progenitors of cord blood.
Sakatoku H; Inoue S
Stem Cells; 1997; 15(4):268-74. PubMed ID: 9253110
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
Rogers CE; Bradley MS; Palsson BO; Koller MR
Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
[TBL] [Abstract][Full Text] [Related]
23. Human erythropoiesis in vitro and the source of burst-promoting activity in a serum-free system.
Konwalinka G; Geissler D; Peschel C; Breier C; Grünewald K; Odavic R; Braunsteiner H
Exp Hematol; 1986 Nov; 14(10):899-903. PubMed ID: 3490394
[TBL] [Abstract][Full Text] [Related]
24. [Expansion of erythroid progenitors and CD34+ cells by umbilical cord blood mononuclear cells].
Zhang JX; Mao P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):429-33. PubMed ID: 15972135
[TBL] [Abstract][Full Text] [Related]
25. Vanadate mimics the effect of stem cell factor on highly purified human erythroid burst-forming units in vitro, but not the effect of erythropoietin.
Dai CH; Krantz S
Exp Hematol; 1992 Oct; 20(9):1055-60. PubMed ID: 1281783
[TBL] [Abstract][Full Text] [Related]
26. [Terminal differentiation of human peripheral blood CD34 positive cells to reticulocytes in vitro and effects of cytoskeletal modifiers on enucleation].
Fukada Y
Hokkaido Igaku Zasshi; 1998 Nov; 73(6):543-56. PubMed ID: 10036613
[TBL] [Abstract][Full Text] [Related]
27. Stem cell factor can overcome inhibition of highly purified human burst-forming units-erythroid by interferon gamma.
Dai CH; Krantz SB; Kollar K; Price JO
J Cell Physiol; 1995 Nov; 165(2):323-32. PubMed ID: 7593210
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures.
Sanders M; Sorba S; Dainiak N
Exp Hematol; 1993 Jan; 21(1):25-30. PubMed ID: 8417957
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 3 (IL-3), but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitro.
Lewis JL; Marley SB; Blackett NM; Szydlo R; Goldman JM; Gordon MY
Cytokine; 1998 Jan; 10(1):49-54. PubMed ID: 9505145
[TBL] [Abstract][Full Text] [Related]
30. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin and hydroxyurea can act on early erythroid progenitors from adult human peripheral blood to modulate fetal globin mRNA levels.
Stoeckert CJ; Green MB
Exp Hematol; 1994 Mar; 22(3):278-82. PubMed ID: 8112426
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone facilitates erythropoiesis in murine embryonic stem cells differentiating into hematopoietic cells in vitro.
Srivastava AS; Kaushal S; Mishra R; Lane TA; Carrier E
Biochem Biophys Res Commun; 2006 Jul; 346(2):508-16. PubMed ID: 16764825
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.
Corre-Buscail I; Pineau D; Boissinot M; Hermouet S
Exp Hematol; 2005 Nov; 33(11):1299-308. PubMed ID: 16263414
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-II: a novel autocrine growth factor modulating the apoptosis and maturation of umbilical cord blood erythroid progenitors.
Nagatomo T; Muta K; Ohga S; Ochiai M; Ohshima K; Hara T
Exp Hematol; 2008 Apr; 36(4):401-11. PubMed ID: 18261839
[TBL] [Abstract][Full Text] [Related]
35. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects.
Wang W; Horner DN; Chen WL; Zandstra PW; Audet J
Biotechnol Bioeng; 2008 Apr; 99(5):1261-72. PubMed ID: 17969148
[TBL] [Abstract][Full Text] [Related]
36. Expression of red cell surface antigens during erythropoiesis.
Daniels G; Green C
Vox Sang; 2000; 78 Suppl 2():149-53. PubMed ID: 10938945
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.
Madkaikar M; Ghosh K; Gupta M; Swaminathan S; Mohanty D
Acta Haematol; 2007; 118(3):153-9. PubMed ID: 17890847
[TBL] [Abstract][Full Text] [Related]
38. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
39. An IL-6/IL-6 soluble receptor (IL-6R) hybrid protein (H-IL-6) induces EPO-independent erythroid differentiation in human CD34(+) cells.
Baiocchi M; Marcucci I; Rose-John S; Serlupi-Crescenzi O; Biffoni M
Cytokine; 2000 Sep; 12(9):1395-9. PubMed ID: 10976001
[TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells.
Kurz K; Gluhcheva Y; Zvetkova E; Konwalinka G; Fuchs D
Immunobiology; 2010 Jun; 215(6):452-7. PubMed ID: 19765856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
